IRX4204 Helps Recovery and Myelin Repair in Mice with Multiple Sclerosis
Author Information
Author(s): Kasheke Gracious D. S., Hendy Basmah A. M., Dorighello Gabriel G., Uccelli Nonthué A., Gothié Jean-David M., Novorolsky Robyn J., Oulton Madison J., Asainayagam Jude, Makarov Adam I., Fraser Kaitlyn S., Vuligonda Vidyasagar, Sanders Martin E., Kennedy Timothy E., Robertson George S.
Primary Institution: Dalhousie University
Hypothesis
Does selective retinoid X receptor agonism promote functional recovery and myelin repair in experimental autoimmune encephalomyelitis?
Conclusion
The study found that IRX4204 significantly improved motor function and reduced myelin loss in mice with experimental autoimmune encephalomyelitis.
Supporting Evidence
- IRX4204 blocked the progressive loss of knee and ankle movements in EAE mice.
- Treatment with IRX4204 reduced white matter loss in the lumbar spinal cord.
- IRX4204 increased the expression of myelin-associated genes in the spinal cord.
- IRX4204 reduced pro-inflammatory gene expression in EAE mice.
- IRX4204 enhanced the differentiation of oligodendrocyte precursor cells in vitro.
Takeaway
Researchers gave a special medicine called IRX4204 to sick mice and found it helped them walk better and fixed their damaged nerves.
Methodology
The study used kinematic gait analysis and various biochemical measurements to assess the effects of IRX4204 on mice with experimental autoimmune encephalomyelitis.
Potential Biases
Clinical scoring may suffer from rater bias.
Limitations
The study did not conclusively demonstrate the specific actions of IRX4204 on different glial cell types involved in myelin repair.
Participant Demographics
Adult female C57BL/6 mice aged 12–14 weeks were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website